Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries ; volume:18 ; number:1 ; day:25 ; month:6 ; year:2018 ; pages:1-12 ; date:12.2018
BMC cardiovascular disorders ; 18, Heft 1 (25.6.2018), 1-12, 12.2018
- Creator
-
Bazargani, Y. T.
- Contributor
-
Ugurlu, M.
de Boer, A.
Leufkens, H. G. M.
Mantel-Teeuwisse, A. K.
SpringerLink (Online service)
- DOI
-
10.1186/s12872-018-0858-5
- URN
-
urn:nbn:de:101:1-2018090115255825830165
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bazargani, Y. T.
- Ugurlu, M.
- de Boer, A.
- Leufkens, H. G. M.
- Mantel-Teeuwisse, A. K.
- SpringerLink (Online service)
Other Objects (12)
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
Associations between essential medicines and health outcomes for cardiovascular disease
Essential medicines for breast cancer in low and middle income countries
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Biologic medicine inclusion in 138 national essential medicines lists
Revising the WHO Essential Medicines List for paediatric rheumatology
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
Associations between essential medicines and health outcomes for cardiovascular disease
Essential medicines for breast cancer in low and middle income countries
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Biologic medicine inclusion in 138 national essential medicines lists
Revising the WHO Essential Medicines List for paediatric rheumatology
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
Associations between essential medicines and health outcomes for cardiovascular disease
Essential medicines for breast cancer in low and middle income countries
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Biologic medicine inclusion in 138 national essential medicines lists